remdesivir Archives -

Close up view of a dedicated worker carrying a stack of duck taped brown boxes in factory storage room while wearing sterile cloths and rubber gloves.

The COVID-19 pandemic has highlighted the importance of ensuring a reliable supply of treatments across the globe at

Improving access to treatments in challenging markets

https://pharmaphorum.com/patients/gilead-jirair-ratevosian-treatment-access/

Gilead says Veklury should work against COVID-19 variants

Phil Taylor coronavirus, COVID-19, drug resistance, Gilead Sciences, remdesivir, Veklury 0 Comment

Gilead Sciences says its antiviral Veklury should be effective against the new, more contagious COVID-19 variants discovered in

Gilead says Veklury should work against COVID-19 variants

https://pharmaphorum.com/news/gilead-says-veklury-should-work-against-covid-19-variants/

News/ News/ Sales and Marketing

Gilead Q3 revenue rise bolstered by $873m Veklury sales

Phil Taylor coronavirus, COVID-19, Financial, Gilead Sciences, remdesivir, Veklury 0 Comment

Gilead Sciences is the first and so far only company to claim FDA approval for a COVID-19 treatment

Gilead Q3 revenue rise bolstered by $873m Veklury sales

https://pharmaphorum.com/news/gilead-q3-revenue-rise-bolstered-by-873m-veklury-sales/

Market Access/ News/ News

Gilead’s remdesivir finally gets US approval

George Underwood coronavirus, COVID-19, Gilead, remdesivir, Veklury 0 Comment

Gilead’s Veklury (remdesivir) has become the first COVID-19 drug approved in the US following a nod from the

Gilead’s remdesivir finally gets US approval

https://pharmaphorum.com/news/gileads-remdesivir-finally-gets-us-approval/

News/ News/ R&D

Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial

Richard Staines COVID-19, Gilead, infectious diseases, R&D, remdesivir 0 Comment

Gilead’s Veklury (remdesivir) has failed to produce an effect on hospital stay and mortality in COVID-19 patients in

Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial

https://pharmaphorum.com/news/gileads-covid-19-drug-veklury-falls-short-in-whos-global-trial/

Market Access/ News/ News

EU ramps up supply of COVID-19 vaccine, drugs

Phil Taylor coronavirus, coronavirus vaccine, COVID-19, EU, European Commission, Gilead Sciences, Johnson & Johnson, remdesivir 0 Comment

The European Commission has taken its advance orders for potential COVID-19 vaccines to more than 1.1 billion, after

EU ramps up supply of COVID-19 vaccine, drugs

https://pharmaphorum.com/news/eu-ramps-up-supply-of-covid-19-vaccine-drugs/

News/ News/ R&D/ Top stories

Trial backs Lilly’s Olumiant plus remdesivir as combo COVID-19 therapy

Phil Taylor coronavirus, COVID-19, Eli Lilly, Gilead Sciences, Olumiant, remdesivir 0 Comment

Adding Eli Lilly’s rheumatoid arthritis drug Olumiant (baricitinib) and Gilead Sciences’ remdesivir reduces recovery time in COVID-19 patients

Trial backs Lilly’s Olumiant plus remdesivir as combo COVID-19 therapy

https://pharmaphorum.com/news/trial-backs-lillys-olumiant-plus-remdesivir-as-combo-covid-19-therapy/

News/ News/ Sales and Marketing

Gilead files COVID-19 drug remdesivir with FDA

Richard Staines coronavirus, COVID-19, infectious diseases, R&D, remdesivir 0 Comment

Gilead has filed its COVID-19 drug remdesivir with the FDA, to treat patients with severe disease, under the

Gilead files COVID-19 drug remdesivir with FDA

https://pharmaphorum.com/news/gilead-files-covid-19-drug-remdesivir-with-fda/

News/ News/ R&D

Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivir

Richard Staines coronavirus, COVID-19, Gilead, infectious diseases, remdesivir 0 Comment

Pfizer has signed a multi-year agreement with Gilead to manufacture and supply the COVID-19 antiviral remdesivir, which is

Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivir

https://pharmaphorum.com/news/pfizer-signs-deal-with-gilead-to-manufacture-covid-19-antiviral-remdesivir/

Trending

remdesivir

Login